{"schema_version":"secwatch.filing_event.v1","accession":"0001906324-24-000025","form_type":"8-K","ticker":"QDEL","cik":"0001906324","company_name":"QuidelOrtho Corp","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.174142+00:00","generated_at":"2026-06-02T20:57:53.284021+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"QuidelOrtho appoints Brian J. Blaser as CEO effective May 6, 2024","bullets":["Blaser, ex-Abbott EVP Diagnostic Products, replaces interim CEO Michael Iskra and interim President Robert Bujarski.","He receives $1M base salary, annual target cash bonus of 125% of base, and equity grants totaling $10M.","Board expanded to 11 members; Blaser joins as director effective May 15, 2024.","Interim Office of the CEO dissolved; Iskra and Bujarski return to prior executive roles."],"urls":{"canonical":"https://secwatch.observer/filing/0001906324-24-000025","json":"https://secwatch.observer/filing/0001906324-24-000025.json","markdown":"https://secwatch.observer/filing/0001906324-24-000025.md","text":"https://secwatch.observer/filing/0001906324-24-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/0001906324-24-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/qdel-20240501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T20:57:53.284021+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"52241a18e2","claim":"Brian J. Blaser was appointed as President and Chief Executive Officer at QuidelOrtho Corp.","evidence_excerpt":"The Board of Directors (the “Board”) of QuidelOrtho Corporation (the “Company”) has appointed Brian J. Blaser to serve as the Company’s President and Chief Executive Officer, effective as of May 6, 2024 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/0001906324-24-000025-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"62d11f8e90","claim":"Robert J. Bujarski changed role as Interim President at QuidelOrtho Corp.","evidence_excerpt":"each of Michael S. Iskra, who served as the Company’s Interim Chief Executive Officer, and Robert J. Bujarski, who served as the Company’s Interim President, stepped down from these interim positions.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/0001906324-24-000025-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Interim President"}],"fact_type":"executive_change"},{"claim_id":"c223f526a1","claim":"Brian J. Blaser was appointed as director at QuidelOrtho Corp.","evidence_excerpt":"In addition, effective as of May 15, 2024, the Board expanded its size from ten to eleven directors and appointed Mr. Blaser to serve as a director until the Company’s 2025 Annual Meeting of Stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/0001906324-24-000025-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"df05ac8163","claim":"Michael S. Iskra changed role as Interim Chief Executive Officer at QuidelOrtho Corp.","evidence_excerpt":"each of Michael S. Iskra, who served as the Company’s Interim Chief Executive Officer, and Robert J. Bujarski, who served as the Company’s Interim President, stepped down from these interim positions.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/0001906324-24-000025-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}